Angiogenesis in cancer and other diseases
The DOI matches its Crossref record; 71 of the 72 references it cites were found in a registry or an index.
Abstract
Pathological angiogenesis is a hallmark of cancer and various ischaemic and inflammatory diseases. Concentrated efforts in this area of research are leading to the discovery of a growing number of pro- and anti-angiogenic molecules, some of which are already in clinical trials. The complex interactions among these molecules and how they affect vascular structure and function in different environments are now beginning to be elucidated. This integrated understanding is leading to the development of a number of exciting and bold approaches to treat cancer and other diseases. But owing to several unanswered questions, caution is needed.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The presence of vascularization is one of the landmarks of tumor environments [57,180].”
From The Tumor-on-Chip: Recent Advances in the Development of Microfluidic Systems to Recapitulate the Physiology of Solid Tumors (2019) · cites this paper as [180]
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Endostatin: an endogenous inhibitor of angiogenesis and tumor growth
O'Reilly, M. S., Boehm, T., Shing, Y., Fukai, N., Vasios, G., Lane, W. S., Flynn, E., Birkhead, J. R., Olsen, B. R., & Folkman, J. (1997) · Cell · doi:10.1016/s0092-8674(00)81848-6 · Cited by 4,486 · cited 1×
“This hypothesis formed the basis of the discovery of angiostatin, endostatin, vasculostatin and other endogenous inhibitors of angiogenesi”
BackgroundMechanisms of angiogenesis and arteriogenesis
Carmeliet, P. (2000) · Nature Medicine · doi:10.1038/74651 · Cited by 4,162 · cited 1×
“We now know there are various molecular players involved in these different mechanisms of vascular growt”
BackgroundSelf-citationAbnormal blood vessel development and lethality in embryos lacking a single VEGF allele
Carmeliet, P., Ferreira, V., Breier, G., Pollefeyt, S., Kieckens, L., Gertsenstein, M., Fahrig, M., Vandenhoeck, A., Harpal, K., Eberhardt, C., et al. (1996) · Nature · doi:10.1038/380435a0 · Cited by 4,117
Self-citationO'Reilly, M. (1994) · Cell · doi:10.1016/0092-8674(94)90200-3 · Cited by 3,345 · cited 1×
“This hypothesis formed the basis of the discovery of angiostatin, endostatin, vasculostatin and other endogenous inhibitors of angiogenesi”
BackgroundRole of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis
Carmeliet, P., Dor, Y., Herbert, J.-M., Fukumura, D., Brusselmans, K., Dewerchin, M., Neeman, M., Bono, F., Abramovitch, R., Maxwell, P., et al. (1998) · Nature · doi:10.1038/28867 · Cited by 2,502 · cited 1×
“However, caution is warranted as these hypoxia-inducible factors could also control cell deat”
BackgroundSelf-citationRegulation of transport pathways in tumor vessels: Role of tumor type and microenvironment
Hobbs, S. K., Monsky, W. L., Yuan, F., Roberts, W. G., Griffith, L., Torchilin, V. P., & Jain, R. K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4607 · Cited by 2,438
Self-citationCancer Treatment by Targeted Drug Delivery to Tumor Vasculature in a Mouse Model
Arap, W., Pasqualini, R., & Ruoslahti, E. (1998) · Science · doi:10.1126/science.279.5349.377 · Cited by 2,054 · cited 1×
“In vivo selection of phage display libraries has recently yielded peptides (for example, amino-acid sequences RGD and NGR) that preferentially recognize vessels in subcutaneous tumours in mic”
BackgroundOpenings Between Defective Endothelial Cells Explain Tumor Vessel Leakiness
Hashizume, H., Baluk, P., Morikawa, S., McLean, J. W., Thurston, G., Roberge, S., Jain, R. K., & McDonald, D. M. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65006-7 · Cited by 1,689
Self-citationHelmlinger, G., Yuan, F., Dellian, M., & Jain, R. K. (1997) · Nature Medicine · doi:10.1038/nm0297-177 · Cited by 1,628
Self-citation
Research works printed but not linked: 8
- Greenblatt, M. & Shubik, P. Tumor angiogenesis: transfilter diffusion studies in the hamster by the transparant chamber technique. J. Natl Cancer Inst. 41, 111–124 (1968).
- Ehrmann, R. L. & Knoth, M. Choriocarcinoma: transfilter stimulation of vasoproliferation in the hamster cheek pouch studied by light and electron microscopy. J. Natl Cancer Inst. 41, 1329 –1341 (1968).
- Folkman, J. in Cancer Medicine (eds Holland, J. F. et al.) 132– 152 (Decker, Ontario, Canada, 2000).
- Chang, Y. S. et al. Abundance of neoplastic cells in vessel walls of human tumor xenografts. Proc. Am. Assoc. Cancer Res. (in the press).
- Seljelid, R., Jozefowski, S. & Sveinbjornsson, B. Tumor stroma. Anticancer Res. 19, 4809–4822 (1999).
- Buschmann, I. & Schaper, W. The pathophysiology of the collateral circulation (arteriogenesis). J. Pathol. 190, 338–342 (2000). · doi:10.1002/(sici)1096-9896(200002)190:3<338::aid-path594>3.0.co;2-7
- Carmeliet, P. & Collen, D. Transgenic mouse models in angiogenesis and cardiovascular disease. J. Pathol. 190, 387–405 (2000). · doi:10.1002/(sici)1096-9896(200002)190:3<387::aid-path595>3.0.co;2-r
- Tsuzuki, Y. et al. VEGF modulation by targeting HIF-1alpha/HRE/VEGF cascade differentially regulates vascular response and growth rate in tumors. Cancer Res. (in the press).
Cited by
Items 1,001–1,084 of 1,084
Review: in vitro microvessel models
Bogorad, M. I., DeStefano, J., Karlsson, J., Wong, A. D., Gerecht, S., & Searson, P. C. (2015) · Lab on a Chip · doi:10.1039/c5lc00832h · Cited by 145
Su, S.-C., Lin, C.-W., Yang, W.-E., Fan, W.-L., & Yang, S.-F. (2016) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2016.1113260 · Cited by 145
“sprout stabilization,[69] most of which are highly correlated with the actions of uPAS components.”
BackgroundBuchanan, C. F., Voigt, E. E., Szot, C. S., Freeman, J. W., Vlachos, P. P., & Rylander, M. N. (2014) · Tissue Engineering Part C: Methods · doi:10.1089/ten.tec.2012.0731 · Cited by 143
“Reverse transcription and PCR amplification was conducted using genespecific TaqMan PCR primers (Applied Biosystems) for matrix metalloproteinase 9 (MMP9), vascular endothelial growth factor (VEGFA), angiopoietin 2 (ANGPT2), and plateletderived growth factor B (PDGFB), which are factors implicated in breast cancer ang…”
MethodZoledronate Sensitizes Endothelial Cells to Tumor Necrosis Factor-induced Programmed Cell Death
Bezzi, M., Hasmim, M., Bieler, G., Dormond, O., & Rüegg, C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308114200 · Cited by 139
Crystal structures of the Tie2 receptor ectodomain and the angiopoietin-2–Tie2 complex
Barton, W. A., Tzvetkova-Robev, D., Miranda, E. P., Kolev, M. V., Rajashankar, K. R., Himanen, J. P., & Nikolov, D. B. (2006) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1101 · Cited by 134
“This arises as a result of two distinct processes termed vasculogenesis (formation of major primitive blood vessels) and angiogenesis (remodeling and extension of the adult vasculature”
BackgroundIntermittent hypoxia induces a metastatic phenotype in breast cancer
Chen, A., Sceneay, J., Gödde, N., Kinwel, T., Ham, S., Thompson, E. W., Humbert, P. O., & Möller, A. (2018) · Oncogene · doi:10.1038/s41388-018-0259-3 · Cited by 133
Rodenhizer, D., Gaude, E., Cojocari, D., Mahadevan, R., Frezza, C., Wouters, B. G., & McGuigan, A. P. (2016) · Nature Materials · doi:10.1038/nmat4482 · Cited by 132
“Immunostaining for HIF1 α also revealed increased nuclear intensities in the inner hypoxic layers (Supplementary Figure 15).”
A microfluidic platform for quantitative analysis of cancer angiogenesis and intravasation
Lee, H., Park, W., Ryu, H., & Jeon, N. L. (2014) · Biomicrofluidics · doi:10.1063/1.4894595 · Cited by 130
3D Matrices for Anti-Cancer Drug Testing and Development
Gurski, L. A., Petrelli, N. J., Jia, X., & Farach-Carson, M. C. (2010) · Oncology Issues · doi:10.1080/10463356.2010.11883480 · Cited by 130
Wada, H., Nagano, H., Yamamoto, H., Yang, Y., Kondo, M., Ota, H., Nakamura, M., Yoshioka, S., Kato, H., Damdinsuren, B., et al. (2006) · Liver International · doi:10.1111/j.1478-3231.2006.01243.x · Cited by 130
“To date, many factors to promote or inhibit angiogenesis have been identified, including growth factors, cytokine or protease (5).”
BackgroundMannino, R. G., Myers, D. R., Ahn, B., Wang, Y., Rollins, M., Gole, H., Lin, A. S., Guldberg, R. E., Giddens, D. P., Timmins, L. H., et al. (2015) · Scientific Reports · doi:10.1038/srep12401 · Cited by 127
Cancer nanomedicine: Addressing the dark side of the enhanced permeability and retention effect
Huynh, E., & Zheng, G. (2015) · Nanomedicine · doi:10.2217/nnm.15.86 · Cited by 125
Dang, D. T., Chen, F., Gardner, L. B., Cummins, J. M., Rago, C., Bunz, F., Kantsevoy, S. V., & Dang, L. H. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2887 · Cited by 122
Policastro, L. L., Ibañez, I. L., Notcovich, C., Duran, H. A., & Podhajcer, O. L. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4367 · Cited by 120
“In the past decades, a plethora of proand antiangiogenic factors that regulate tumor angiogenesis have been identified (5, 25, 41).”
InfluentialNexus between in silico and in vivo models to enhance clinical translation of nanomedicine
Moradi Kashkooli, F., Soltani, M., Souri, M., Meaney, C., & Kohandel, M. (2021) · Nano Today · doi:10.1016/j.nantod.2020.101057 · Cited by 120
Yang, L., Morielli, A. R., Heer, E., Kirkham, A. A., Cheung, W. Y., Usmani, N., Friedenreich, C. M., & Courneya, K. S. (2021) · Cancer Research · doi:10.1158/0008-5472.can-21-1258 · Cited by 118
“Notably, the proangiogenic nature of exercise may, in principle, fuel tumor growth in the absence of treatment (32); however, in combinationwith treatment, exercisemay improve the delivery of anticancer therapies to the tumor through its effects on blood flow (33).”
BackgroundThe blood brain barrier in Alzheimer’s disease
Chakraborty, A., de Wit, N. M., van der Flier, W. M., & de Vries, H. E. (2017) · Vascular Pharmacology · doi:10.1016/j.vph.2016.11.008 · Cited by 118
Low levels of physiological interstitial flow eliminate morphogen gradients and guide angiogenesis
Shirure, V. S., Lezia, A., Tao, A., Alonzo, L. F., & George, S. C. (2017) · Angiogenesis · doi:10.1007/s10456-017-9559-4 · Cited by 117
“interest in the tumor microenvironment, as the elevation of interstitial flow and vascular endothelial growth factor (VEGF) are both correlated with tumor progression [1, 3].”
BackgroundInfluentialJain, R. K., Finn, A. V., Kolodgie, F. D., Gold, H. K., & Virmani, R. (2007) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio0979 · Cited by 117
“These new vessels can grow from the existing host vessels, via angiogenesis, and by recruitment of cells from the bone marrow, via postnatal vasculogenesis”
BackgroundSelf-citationRecent developments in the regulation of the angiogenic switch by cellular stress factors in tumors
North, S., Moenner, M., & Bikfalvi, A. (2005) · Cancer Letters · doi:10.1016/j.canlet.2004.08.007 · Cited by 113
“Oxidative stress represents another stimulus that may contribute to tumor angiogenesis [20].”
BackgroundSullivan, R., Maresh, G., Zhang, X., Salomon, C., Hooper, J., Margolin, D., & Li, L. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00194 · Cited by 112
“Angiogenesis As a tumor begins to proliferate, it requires increasing amounts of oxygen and nutrients to support the enlarging cellular population, making angiogenesis a necessary mechanism for tumor survival (73).”
BackgroundAnti-angiogenic effect of siphonaxanthin from green alga, Codium fragile
Ganesan, P., Matsubara, K., Ohkubo, T., Tanaka, Y., Noda, K., Sugawara, T., & Hirata, T. (2010) · Phytomedicine · doi:10.1016/j.phymed.2010.05.005 · Cited by 112
“01% of endothelial cells undergoing division (Carmeliet and Jain, 2000).”
InfluentialHofmann, M., Guschel, M., Bernd, A., Bereiter-Hahn, J., Kaufmann, R., Tandi, C., Wiig, H., & Kippenberger, S. (2006) · Neoplasia · doi:10.1593/neo.05469 · Cited by 106
“the abnormal vasculature in the tumor area give rise to hypertension [6–8].”
BackgroundMechanisms of Hypoxic Gene Regulation of Angiogenesis Factor Cyr61 in Melanoma Cells
Kunz, M., Moeller, S., Koczan, D., Lorenz, P., Wenger, R. H., Glocker, M. O., Thiesen, H.-J., Gross, G., & Ibrahim, S. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301373200 · Cited by 104
Ogawara, K.-I., Un, K., Tanaka, K.-I., Higaki, K., & Kimura, T. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.09.008 · Cited by 101
Liu, J., Hao, H., Xia, L., Ti, D., Huang, H., Dong, L., Tong, C., Hou, Q., Zhao, Y., Liu, H., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0126715 · Cited by 101
Christen, T., Pannetier, N. A., Ni, W. W., Qiu, D., Moseley, M. E., Schuff, N., & Zaharchuk, G. (2014) · NeuroImage · doi:10.1016/j.neuroimage.2013.11.052 · Cited by 97
“All these parameters contributing to BOLD are potentially important biomarkers for studying angiogenesis or hypoxic processes in pathologies such as cancer (Carmeliet and Jain, 2000; Vaupel and Mayer, 2007) or stroke (Sobesky et al.”
BackgroundLee, H.-P., Lin, C.-Y., Shih, J.-S., Fong, Y.-C., Wang, S.-W., Li, T.-M., & Tang, C.-H. (2015) · Oncotarget · doi:10.18632/oncotarget.5479 · Cited by 94
“The process of angiogenesis mainly involves endothelial cells proliferation, migration, and tube formation to form new blood vessels [29].”
Imaging of anticancer drug action in single cells
Miller, M. A., & Weissleder, R. (2017) · Nature reviews. Cancer · doi:10.1038/nrc.2017.41 · Cited by 92
Telomerase and telomeres in aging theory and chronographic aging theory (Review)
Razgonova, M., Zakharenko, A., Golokhvast, K., Thanasoula, M., Sarandi, E., Nikolouzakis, K., Fragkiadaki, P., Tsoukalas, D., Spandidos, D., & Tsatsakis, A. (2020) · Molecular Medicine Reports · doi:10.3892/mmr.2020.11274 · Cited by 89
“…activity that can contribute to tumor development by inducing vessel permeability that facilitates tumor cell proliferation and metastasis (122). although VeGF-a appears not to regulate telomerase activity in human umbilical vein endothelial cells (123), VeGF and lysophosphatidic acid…”
Tumor vascular infarction: prospects and challenges
Jahanban-Esfahlan, R., Seidi, K., & Zarghami, N. (2017) · International Journal of Hematology · doi:10.1007/s12185-016-2171-3 · Cited by 88
Endothelial YAP/TAZ Signaling in Angiogenesis and Tumor Vasculature
Hooglugt, A., van der Stoel, M. M., Boon, R. A., & Huveneers, S. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.612802 · Cited by 82
Exploring the Potential of Nanotherapeutics in Targeting Tumor Microenvironment for Cancer Therapy
Muntimadugu, E., Kommineni, N., & Khan, W. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.05.010 · Cited by 82
Effects of hypoxia and nanocarrier size on pH-responsive nano-delivery system to solid tumors
Soltani, M., Souri, M., & Moradi Kashkooli, F. (2021) · Scientific Reports · doi:10.1038/s41598-021-98638-w · Cited by 82
Uniform Beads with Controllable Pore Sizes for Biomedical Applications
Choi, S., Yeh, Y., Zhang, Y., Sung, H., & Xia, Y. (2010) · Small · doi:10.1002/smll.201000544 · Cited by 81
VEGFR1 promotes cell migration and proliferation through PLCγ and PI3K pathways
Weddell, J. C., Chen, S., & Imoukhuede, P. I. (2017) · npj Systems Biology and Applications · doi:10.1038/s41540-017-0037-9 · Cited by 80
Block, K. M., Wang, H., Szabó, L. Z., Polaske, N. W., Henchey, L. K., Dubey, R., Kushal, S., László, C. F., Makhoul, J., Song, Z., et al. (2009) · Journal of the American Chemical Society · doi:10.1021/ja807601b · Cited by 79
Tei, K., Matsumoto, T., Mifune, Y., Ishida, K., Sasaki, K., Shoji, T., Kubo, S., Kawamoto, A., Asahara, T., Kurosaka, M., et al. (2008) · Stem Cells · doi:10.1634/stemcells.2007-0671 · Cited by 78
Wang, X.-Y., Pei, Y., Xie, M., Jin, Z.-H., Xiao, Y.-S., Wang, Y., Zhang, L.-N., Li, Y., & Huang, W.-H. (2015) · Lab on a Chip · doi:10.1039/c4lc00973h · Cited by 77
Peptide-protein Coassembling Matrices as a Biomimetic 3D Model of Ovarian Cancer
Hedegaard, C. L., Redondo-Gómez, C., Tan, B. Y., Ng, K. W., Loessner, D., & Mata, A. (2020) · Science Advances · doi:10.1126/sciadv.abb3298 · Cited by 76
“However, this phenomenon is only observed when the spheroids or tumor mass reaches a diameter of >200 m, at which point diffusion is inhibited, eventually leading to a hypoxic core (47).”
BackgroundRETRACTED: Bifidobacteria Expressing Tumstatin Protein for Antitumor Therapy in Tumor-Bearing Mice
Wei, C., Xun, A. Y., Wei, X. X., Yao, J., Wang, J. Y., Shi, R. Y., Yang, G. H., Li, Y. X., Xu, Z. L., Lai, M. G., et al. (2016) · Technology in Cancer Research & Treatment · doi:10.1177/1533034615581977 · Cited by 75
“Uncontrolled angiogenesis plays an important role in tumor growth,(2) and newly formed blood vessels mediate tumor metastasis.(3,4) Uncontrolled angiogenesis is required for tumor growth, which is a result of the imbalance between the amounts of growth factors and growth inhibition factors.”
BackgroundRetractedNicoli, S., De Sena, G., & Presta, M. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00432.x · Cited by 74
“Angiogenesis plays a key role in tumour growth and metastasis [1].”
BackgroundGene Therapy Intervention in Neovascular Eye Disease: A Recent Update
Lin, F.-L., Wang, P.-Y., Chuang, Y.-F., Wang, J.-H., Wong, V. H. Y., Bui, B. V., & Liu, G.-S. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.06.029 · Cited by 74
Sun, B., Zhang, S., Ni, C., Zhang, D., Liu, Y., Zhang, W., Zhao, X., Zhao, C., & Shi, M. (2005) · Stem Cells and Development · doi:10.1089/scd.2005.14.292 · Cited by 72
“Evidence has shown that tumor vessels are derived from capillaries and veins in the host tissue, by the mechanism of activating pre-existing endothelial cells by pro-angiogenic factors that then migrate into the tumor and develop into new vessel networks (2,3).”
The dual roles of homeobox genes in vascularization and wound healing
Kachgal, S., Mace, K. A., & Boudreau, N. J. (2012) · Cell Adhesion & Migration · doi:10.4161/cam.22164 · Cited by 72
“For this reason, nearly every cell in the human body lies at a distance no further than 100–200 mm from a blood vessel, which correlates with the mathematically-calculated limit at which oxygen tension reaches a critical level for cell survival.(1,2) Not surprisingly, regulation of vascular development is closely tied…”
BackgroundObesity and Cancer: An Angiogenic and Inflammatory Link
Fukumura, D., Incio, J., Shankaraiah, R. C., & Jain, R. K. (2016) · Microcirculation · doi:10.1111/micc.12270 · Cited by 69
“, VEGF, PLGF] and exhibits angiogenic activity [18,33,99].”
BackgroundSelf-citationYamamoto, A., Huang, Y., Krajina, B. A., McBirney, M., Doak, A. E., Qu, S., Wang, C. L., Haffner, M. C., & Cheung, K. J. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2214888120 · Cited by 69
STIM-Orai Channels and Reactive Oxygen Species in the Tumor Microenvironment
Frisch, J., Angenendt, A., Hoth, M., Prates Roma, L., & Lis, A. (2019) · Cancers · doi:10.3390/cancers11040457 · Cited by 68
“Low oxygen tension (hypoxia) promotes metastasis and is considered as the key driver in angiogenesis [101,102].”
BackgroundMolecular heterogeneity of tumor endothelium
Aird, W. C. (2009) · Cell and Tissue Research · doi:10.1007/s00441-008-0672-y · Cited by 66
“It is not clear whether the tumor cells mimic endothelial cell function (vasculogenic mimicry) or whether they simply invade the vascular wall and/or become exposed to blood following endothelial cell apoptosis (for a review, see Carmeliet and Jain 2000 ).”
BackgroundNovello, S., Kaiser, R., Mellemgaard, A., Douillard, J.-Y., Orlov, S., Krzakowski, M., von Pawel, J., Gottfried, M., Bondarenko, I., Liao, M., et al. (2015) · European Journal of Cancer · doi:10.1016/j.ejca.2014.11.015 · Cited by 66
“Angiogenesis is critical for the growth, progression and metastasis of many solid tumour types, and so it represents a fundamental target for cancer therapy [12,13].”
The insulin-like growth factor system in multiple myeloma: diagnostic and therapeutic potential
Bieghs, L., Johnsen, H. E., Maes, K., Menu, E., Van Valckenborgh, E., Overgaard, M. T., Nyegaard, M., Conover, C. A., Vanderkerken, K., & De Bruyne, E. (2016) · Oncotarget · doi:10.18632/oncotarget.8982 · Cited by 61
“An imbalance in the levels of these pro- and anti-angiogenic factors contributes to the pathogenesis of different disorders, including cancer [116].”
BackgroundNarazaki, M., Segarra, M., & Tosato, G. (2008) · Blood · doi:10.1182/blood-2007-09-112474 · Cited by 59
New therapies for dedifferentiated papillary thyroid cancer
Fallahi, P., Mazzi, V., Vita, R., Ferrari, S., Materazzi, G., Galleri, D., Benvenga, S., Miccoli, P., & Antonelli, A. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms16036153 · Cited by 58
“Experimental evidence has shown that thyroid neoplastic growth and subsequent metastasis formation depend on the tumor’s ability to induce an angiogenic switch, induced by a change in the balance of angiogenic stimulators and inhibitors [30,31].”
BackgroundSpecific cell targeting with APRPG conjugated PEG–PLGA nanoparticles for treating ovarian cancer
Wang, Y., Liu, P., Duan, Y., Yin, X., Wang, Q., Liu, X., Wang, X., Zhou, J., Wang, W., Qiu, L., et al. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2013.09.062 · Cited by 56
“Angiogenesis is closely associated with tumor growth and metastasis and is of particular relevance in ovarian cancer [5,6], and”
BackgroundHeylman, C., Sobrino, A., Shirure, V. S., Hughes, C. C., & George, S. C. (2014) · Experimental Biology and Medicine · doi:10.1177/1535370214525295 · Cited by 53
“Vascular permeability undergoes significant changes in pathological conditions such as wound healing, chronic inflammatory diseases, and cancer.(25) Unlike arteries and veins, capillaries consist of little more than a layer of endothelial cells (ECs) and connective tissue, along with a sparse covering of pericytes.”
BackgroundBoudria, A., Abou Faycal, C., Jia, T., Gout, S., Keramidas, M., Didier, C., Lemaître, N., Manet, S., Coll, J.-L., Toffart, A.-C., et al. (2019) · Oncogene · doi:10.1038/s41388-018-0486-7 · Cited by 53
Trani, M., & Dejana, E. (2015) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000137 · Cited by 52
“Furthermore, cancer cells induce the formation of their own vascular system by recruiting new vessels from the host [17,18].”
BackgroundLoh, J., & Gulati, A. (2015) · Pain Medicine · doi:10.1111/pme.12038 · Cited by 51
Sawadkar, P., Mandakhbayar, N., Patel, K. D., Buitrago, J. O., Kim, T. H., Rajasekar, P., Lali, F., Kyriakidis, C., Rahmani, B., Mohanakrishnan, J., et al. (2021) · Journal of Tissue Engineering · doi:10.1177/20417314211019238 · Cited by 51
Effectiveness factor and diffusion limitations in collagen gel modules containing HepG2 cells
Corstorphine, L., & Sefton, M. V. (2011) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.296 · Cited by 43
Li, Y., Pasunooti, K. K., Li, R.-J., Liu, W., Head, S. A., Shi, W. Q., & Liu, J. O. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01252 · Cited by 43
Leveraging microenvironmental synthetic lethalities to treat cancer
Metcalf, K. J., Alazzeh, A., Werb, Z., & Weaver, V. M. (2021) · Journal of Clinical Investigation · doi:10.1172/jci143765 · Cited by 42
“Yet many tumors are abnormally and poorly vascularized, which causes nutrient-poor and hypoxic regions within tumors (101).”
BackgroundTodorich, B., Faia, L. J., Thanos, A., Amin, M., Folberg, R., Wolfe, J. D., Todorich, K. M., Raphtis, E., Ruby, A. J., Williams, G. A., et al. (2018) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2018.01.030 · Cited by 42
Angiogenesis is crucial for liver regeneration after partial hepatectomy
Uda, Y., Hirano, T., Son, G., Iimuro, Y., Uyama, N., Yamanaka, J., Mori, A., Arii, S., & Fujimoto, J. (2013) · Surgery · doi:10.1016/j.surg.2012.06.021 · Cited by 41
Blood vessels and Parkinsonism
Barcia, C. (2004) · Frontiers in Bioscience · doi:10.2741/1145 · Cited by 41
“For example, hypoxia, hypoglycemia, or inflammation are triggers for an angiogenic response (31, 32, 33, 34).”
BackgroundKirtane, A. R., Sadhukha, T., Kim, H., Khanna, V., Koniar, B., & Panyam, J. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-1646 · Cited by 38
“Tumor blood vessels are formed in response to pro-angiogenic factors secreted by tumor cells (28).”
Murthy, A., Gerber, S. A., Koch, C. J., & Lord, E. M. (2019) · ImmunoHorizons · doi:10.4049/immunohorizons.1900017 · Cited by 36
“Strategies such as hyperbaric chambers, angiogenesis inhibitors, and radiosensitizer molecules were developed to improve the oxygenation status of tumors and circumvent the problem of radiation resistance (12).”
Durymanov, M., Kroll, C., Permyakova, A., O'Neill, E., Sulaiman, R., Person, M., & Reineke, J. (2019) · Translational Oncology · doi:10.1016/j.tranon.2018.10.003 · Cited by 34
Bruch’s Membrane and the Choroid in Age-Related Macular Degeneration
Edwards, M., & Lutty, G. A. (2021) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-030-66014-7_4 · Cited by 32
Radiotherapy in combination with vascular-targeted therapies
Ciric, E., & Sersa, G. (2010) · Radiology and Oncology · doi:10.2478/v10019-010-0025-9 · Cited by 30
Sun, B., Liang, Z., Wang, Y., Yu, Y., Zhou, X., Geng, X., & Li, B. (2024) · Toxicology · doi:10.1016/j.tox.2024.153829 · Cited by 30
Schmid, S. A., Gaumann, A., Wondrak, M., Eckermann, C., Schulte, S., Mueller-Klieser, W., Wheatley, D. N., & Kunz-Schughart, L. A. (2007) · Experimental Cell Research · doi:10.1016/j.yexcr.2007.05.016 · Cited by 26
“percentage of mature vessels, and vascular targeting could be more limited than expected from animal models [37,42,43].”
BackgroundInvestigating the Effects of Stove Emissions on Ocular and Cancer Cells
Karakoçak, B. B., Patel, S., Ravi, N., & Biswas, P. (2019) · Scientific Reports · doi:10.1038/s41598-019-38803-4 · Cited by 26
Bou Assaf, R., Fayyad-Kazan, M., Al-Nemer, F., Makki, R., Fayyad-Kazan, H., Badran, B., & Berbéri, A. (2019) · BioMed Research International · doi:10.1155/2019/2868673 · Cited by 25
“Following implantation to the injured site, the diffusing interstitial fluid will be the only source of nourishment for the cells on the biomaterial [14, 15].”
BackgroundInfluentialIm, J. H., Tapmeier, T., Balathasan, L., Gal, A., Yameen, S., Hill, S., Smart, S., Noterdaeme, O., Kelly, M., Brady, M., et al. (2013) · International Journal of Cancer · doi:10.1002/ijc.27677 · Cited by 25
“The angiopoietins and their receptors mediate angiogenesis during vascular development.(4,5) They clearly play a critical role in tumor angiogenesis, but the details including involvement in tumor metastasis are not clearly defined.”
BackgroundAbouelnazar, F. A., Zhang, X., Zhang, J., Wang, M., Yu, D., Zang, X., Zhang, J., Li, Y., Xu, J., Yang, Q., et al. (2023) · Cancer Cell International · doi:10.1186/s12935-023-02985-9 · Cited by 24
“Tumor blood vessels deliver oxygen and nutrients to tumor tissue, allowing it to grow rapidly and spread to distant locations [6].”
BackgroundRole of endothelial cell-selective adhesion molecule in hematogeneous metastasis
Cangara, H. M., Ishida, T., Hara, T., Sun, L., Toh, R., Rikitake, Y., Kundu, R. K., Quertermous, T., Hirata, K.-I., & Hayashi, Y. (2010) · Microvascular Research · doi:10.1016/j.mvr.2010.02.006 · Cited by 23
“Angiogenesis consists of several processes including endothelial cell activation, proliferation, migration, tube formation and capillary sprouting (Carmeliet and Jain, 2000).”
BackgroundLiu, Y., Xia, Y., Smollar, J., Mao, W., & Wan, Y. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2021.188539 · Cited by 23
Courtaut, F., Scagliarini, A., Aires, V., Cornebise, C., Pais de Barros, J.-P., Olmiere, C., & Delmas, D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126590 · Cited by 17
“Despite an increasing number of reports highlighting the key role of VEGF-A in the development of blood vessels in tumors and other tissues undergoing abnormal angiogenesis [27,28], and the development of new anti-VEGF antibodies to counteract neovascularization, especially in advanced cancers or in ocular diseases (i.”
BackgroundAmlodipine accelerates bone healing in a stable closed femoral fracture model in mice
Department of Trauma and Reconstructive Surgery, E. K. U. T., Menger, M., Merscher, B., Scheuer, C., Braun, B., Herath, S., Rollmann, M., Stenger, D., Später, T., Pohlemann, T., et al. (2021) · European Cells and Materials · doi:10.22203/ecm.v041a38 · Cited by 16
Chung, K.-S., Choi, H.-E., Shin, J.-S., Cho, E.-J., Cho, Y.-W., Choi, J.-H., Baek, N.-I., & Lee, K.-T. (2015) · Food and Chemical Toxicology · doi:10.1016/j.fct.2014.11.007 · Cited by 14
Kim, H., Ahn, T. S., Kim, C.-J., Bae, S. B., Kim, H. J., Lee, C.-S., Kim, T. H., Im, J., Lee, S. H., Son, M. W., et al. (2017) · Oncology Letters · doi:10.3892/ol.2017.6203 · Cited by 8
“As metastatic colon cancer is associated with high mortality (10,11), progression to metastasis is a turning point for CRC development, which depends on an angiogenic network (12).”
Anti-Cancer Treatment Strategies in the Older Population: Time to Test More?
Tralongo, A. C., Fratamico, R. S., Russo, C., Sbrana, A., Antonuzzo, A., & Danova, M. (2021) · Geriatrics · doi:10.3390/geriatrics6020042 · Cited by 4
“They are produced in a high fraction by tumor cells [30].”
BackgroundDenzer, L., Muranyi, W., Herold, R., Stump-Guthier, C., Ishikawa, H., Sticht, C., Schroten, H., Schwerk, C., & Weichert, S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26041779 · Cited by 3
“…cells, which line the innermost layer of blood vessels, can sense shear stress, adjust the diameter and thickness of the vessel wall accordingly through molecular signaling pathways, and control the migration of immune cells and the transport of molecules in and out of the bloodstream [1–3].”
Metadata
- Authors
- Carmeliet, P., & Jain, R. K.
- Affiliations
- Vlaams Instituut voor Biotechnologie (BE)
- Harvard University (US)
- ORCID
- Carmeliet, Peter
- Venue
- Nature
- Published
- 2000-09
- Volume
- 407
- Issue
- 6801
- Pages
- 249-257
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1573363574
- Cited by
- 9,070
- References
- 72
- Citations by year
- 2026: 166 · 2025: 208 · 2024: 246 · 2023: 330 · 2022: 335 · 2021: 381 · 2020: 368 · 2019: 349 · 2018: 375 · 2017: 380 · 2016: 378 · 2015: 364 · 2014: 414 · 2013: 412 · 2012: 416
- FWCI
- 19.82
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Institutes of Health
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Health Sciences › Medicine › Oncology › Lymphatic System and Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Keywords
- pathological angiogenesis, cancer, ischemic diseases, inflammatory diseases, anti-angiogenic therapy, clinical trials
- MeSH terms
- Animals, Disease, Humans, Lymphokines, Neoplasms, Neovascularization, Pathologic, Endothelial Growth Factors, Vascular Endothelial Growth Factors, Vascular Endothelial Growth Factor A
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.